Skip to main content

Table 3 Enrichment-fold (≥20) of independent LD blocks in the Geuvadis data

From: Prediction of gene expression with cis-SNPs using mixed models and regularization methods

Enrichment fold

#Identified SNPs

Chromosome

LD block

lower

upper

26.58

16

2

84,687,169

84,743,579

53.20

11

2

152,118,393

152,146,571

22.76

17

3

19,988,517

20,053,822

184.35

8

3

75,713,481

75,721,542

27.75

17

3

161,090,668

161,144,215

36.70

15

4

44,680,444

44,728,612

81.95

8

4

47,465,736

47,487,305

34.18

13

5

107,006,596

107,052,542

32.41

25

7

120,965,421

121,036,418

299.82

29

10

18,940,551

18,948,334

45.61

12

10

131,909,081

131,934,663

28.64

8

12

127,210,816

127,256,957

44.88

23

12

129,308,528

129,337,972

22.28

17

13

101,241,782

101,327,347

29.80

13

16

5,084,142

5,147,789

23.06

22

18

23,671,164

23,806,409

151.19

16

18

61,616,535

61,637,159

  1. We obtained a total of 18,896 complete records (mainly including the information of disease/trait, chromosome id and position) of identified SNPs by GWASs from https://www.genome.gov/gwastudies/. We counted the number (given in the second column) of related SNPs within 1 Mb upstream and downstream regions near each LD block. These identified SNPs are extensively related to about 130 different types of complex diseases and traits. For example, in the first LD block (Chr2: 84,687,169-84,743,579), previous GWASs have discovered 16 associated SNPs, which, in terms of the catalog of published GWASs, are related to aging traits, protein quantitative trait loci, pulmonary function decline, IgG glycosylation, RR interval heart rate, the response to antipsychotic therapy, coronary artery calcification, prostate cancer, response to cytadine analogues cytosine arabinoside, bilirubin levels, orthostatic hypotension, breast cancer and conduct disorder